Immune Checkpoint Inhibitor-Related Cardiotoxicity
References
- Johnson DB Balko JM Compton ML Fulminant Myocarditis with Combination Immune Checkpoint Blockade N Engl J Med 2016 Nov 3 375 18 1749 55
- Behling J Kaes J Munzel T Grabbe S Loquai C New-onset third-degree atrioventricular block because of autoimmune-induced myositis under treatment with anti-programmed cell death-1 (nivolumab) for metastatic melanoma Melanoma Res 2017 Apr 27 2 155 8
- Semper H Muehlberg F Schulz-Menger J Allewelt M Grohe C Drug-induced myocarditis after nivolumab treatment in a patient with PDL1-negative squamous cell carcinoma of the lung Lung Cancer 2016 Sep 99 117 9
- Wang DY Okoye GD Neilan TG Johnson DB Moslehi JJ Cardiovascular Toxicities Associated with Cancer Immunotherapies Curr Cardiol Rep 2017 Mar 19 3 21
- Varricchi G Galdiero MR Tocchetti CG Cardiac Toxicity of Immune Checkpoint Inhibitors: Cardio-Oncology Meets Immunology Circulation 2017 Nov 21 136 21 1989 92
- Escudier M Cautela J Malissen N Clinical Features, Management, and Outcomes of Immune Checkpoint Inhibitor-Related Cardiotoxicity Circulation 2017 Nov 21 136 21 2085 7
- Trachtenberg BH Hare JM Inflammatory Cardiomyopathic Syndromes Circ Res 2017 121 7 803 18
- Mahmood SS Fradley MG Cohen JV Myocarditis in Patients Treated With Immune Checkpoint Inhibitors J Am Coll Cardiol 2018 Apr 24 71 16 1755 64
- Nishimura H Okazaki T Tanaka Y Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice Science 2001 Jan 12 291 5502 319 22
DOI: https://doi.org/10.14797/mdcvj.842 | Journal eISSN: 1947-6108
Language: English
Published on: Jul 1, 2018
Published by: Houston Methodist DeBakey Heart & Vascular Center
In partnership with: Paradigm Publishing Services
Keywords:
© 2018 Barry Trachtenberg, Fahd Hussain, Akash Mukherjee, Raquel Araujo-Gutierrez, Sai ravi kiran Pingali, published by Houston Methodist DeBakey Heart & Vascular Center
This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 License.